AME profit rises 26% to SAR 33.5M in 2023

AME profit rises 26% to SAR 33.5M in 2023

25/03/2024 Argaam Exclusive

View other reports

AME Company for Medical Supplies posted a net profit rise of 26% to SAR 33.5 million in 2023 from SAR 26.7 million in 2022.



Financials (M)

Item 2022 2023 Change‬
Revenues 193.17 223.32 15.6 %
Gross Income 90.28 98.75 9.4 %
Operating Income 29.98 36.48 21.7 %
Net Income 26.68 33.52 25.6 %
Average Shares 7.00 7.00 -
EPS (Riyals) 3.81 4.79 25.6 %

The company recorded a rise in the annual net revenue (net sales revenues) by SAR 30.15 million, mainly due to increased sales of medical supplies and medical equipment. This increase was backed by AME capturing a larger market share.



Shareholders’ equity, no minority interest, reached SAR 127.16 million as of Dec. 31, 2023, up from SAR 107.34 million a year earlier.

 

Historical Data

Period

Revenue

(SAR mln)

Net Profit

(SAR mln)

EPS

(SAR)

H1 2020

44.66

4.18

0.60

H2 2020

76.94

16.89

2.41

H1 2021

69.78

7.50

1.07

H2 2021

81.61

13.72

1.96

H1 2022

108.35

15.38

2.20

H2 2022

84.82

11.30

1.61

H1 2023

120.34

22.20

3.17

H2 2023

102.98

11.32

1.62

 

View more financial results

 


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2014 - - - - - - -
Q2 2014 - - - - - - -
Q3 2014 - - - - - - -
Q4 2014 - - - - - - -
Q1 2015 - - - - - - -
Q2 2015 - - - - - - -
Q3 2015 - - - - - - -
Q4 2015 - - - - - - -
Q1 2016 - - - - - - -
Q2 2016 - - - - - - -
Q3 2016 - - - - - - -
Q4 2016 - - - - - - -
Q1 2017 - - - - - - -
Q2 2017 - - - - - - -
Q3 2017 - - - - - - -
Q4 2017 - - - - - - -
Q1 2018 - - - - - - -
Q2 2018 - - - - - - -
Q3 2018 - - - - - - -
Q4 2018 - - - - - - -
Q1 2019 - - - - - - -
Q2 2019 - - - - - - -
Q3 2019 - - - - - - -
Q4 2019 - - - - - - -
Q1 2020 31.44 - 15.42 - 3.36 - 0.48
Q2 2020 - - - - - - -
Q3 2020 - - - - - - -
Q4 2020 - - - - - - -
Q1 2021 32.16 2.3 % 15.17 (1.6 %) 5.58 65.9 % 0.80
Q2 2021 37.62 - 16.83 - 1.92 - 0.27
Q3 2021 - - - - - - -
Q4 2021 - - - - - - -
Q1 2022 54.29 68.8 % 22.22 46.5 % 5.87 5.3 % 0.84
Q2 2022 54.06 43.7 % 26.64 58.3 % 9.51 395.1 % 1.36
Q3 2022 - - - - - - -
Q4 2022 - - - - - - -
Q1 2023 66.17 21.9 % 30.51 37.3 % 13.00 121.4 % 1.86
Q2 2023 54.17 0.2 % 25.18 (5.5 %) 9.19 (3.3 %) 1.31
Q3 2023 - - - - - - -
Q4 2023 - - - - - - -
2023 223.32 15.6 % 98.75 9.4 % 33.52 25.6 % 4.79

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 49.05 % - 10.69 %
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 48.10 % - 14.06 %
Q2 2021 46.85 % - 15.00 %
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 44.78 % - 13.54 %
Q2 2022 45.39 % - 15.27 %
Q3 2022 - - -
Q4 2022 - - -
Q1 2023 45.35 % - 16.32 %
Q2 2023 45.72 % - 16.43 %
Q3 2023 - - -
Q4 2023 - - -
2023 44.22 % 17.02 % 15.01 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 7.00 0.48 0.48 -
Q2 2020 - - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 7.00 1.28 1.28 -
Q2 2021 7.00 1.55 2.17 11.72
Q3 2021 - - - -
Q4 2021 - - - -
Q1 2022 7.00 2.39 3.01 -
Q2 2022 7.00 3.27 3.89 13.79
Q3 2022 - - - -
Q4 2022 - - - -
Q1 2023 7.00 4.33 4.95 -
Q2 2023 7.00 5.37 5.37 16.51
Q3 2023 - - - -
Q4 2023 - - - -

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 23.43 18.62 -
Q2 2022 13.31 11.20 3.15
Q3 2022 - - -
Q4 2022 - - -
Q1 2023 9.65 8.44 -
Q2 2023 8.79 8.79 2.86
Q3 2023 - - -
Q4 2023 - - -

Business Segments (Million)

Compared With The
Period Medical supplies medical tools Maintenance & Management sector Others


Financial Ratios
Current
Market Cap (M Riyal) 415.10
Enterprise Value (EV) (M) 371.70
Shares Outstanding ((M)) 7.00
Book Value (BV) ( Riyal) 18.17
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 12.39
Price/book 3.26
more

Share Price

AME Company for Medical Supplies
59.30
(0.20) (0.34 %)

AME Company for Medical Supplies (AME)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.